LOGIN  |  REGISTER

Recent Insider Transactions - AN2 Therapeutics (NASDAQ: ANTX)

Follow NASDAQ:ANTX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ANTX AN2 Therapeutics
Leonard Braden Michael / 10 percent owner
05/28/2025
Sell
$1.09
200,000
$218K
3.02M
NASDAQ ANTX AN2 Therapeutics
Easom Eric / director, officer: Chief Executive Officer
06/02/2025
Buy
$1.07
10,000
$11K
256,380
NASDAQ ANTX AN2 Therapeutics
Leonard Braden Michael / 10 percent owner
05/28/2025
Sell
$1.16
2.00M
$2.320M
3.75M
NASDAQ ANTX AN2 Therapeutics
Leonard Braden Michael / 10 percent owner
05/28/2025
Sell
$1.16
100,000
$116K
3.65M
NASDAQ ANTX AN2 Therapeutics
Leonard Braden Michael / 10 percent owner
05/30/2025
Sell
$1.01
425,000
$429K
3.22M
NASDAQ ANTX AN2 Therapeutics
Leonard Braden Michael / 10 percent owner
05/30/2025
Sell
$1.03
7,000
$7K
3.22M
NASDAQ ANTX AN2 Therapeutics
FitzPatrick Margaret M / director
05/28/2025
Buy
$1.18
8,610
$10K
8,610
NASDAQ ANTX AN2 Therapeutics
Readnour Robin Shane / director
05/22/2025
Buy
$1.19
19,111
$23K
19,111
NASDAQ ANTX AN2 Therapeutics
Martin Patricia A. / director
05/22/2025
Buy
$1.19
19,111
$23K
19,111
NASDAQ ANTX AN2 Therapeutics
FitzPatrick Margaret M / director
05/22/2025
Buy
$1.19
19,111
$23K
19,111
NASDAQ ANTX AN2 Therapeutics
Zakrzewski Joseph S / director
05/22/2025
Buy
$1.19
19,111
$23K
19,111
NASDAQ ANTX AN2 Therapeutics
Spigelman Melvin K / director
05/22/2025
Buy
$1.19
19,111
$23K
19,111
NASDAQ ANTX AN2 Therapeutics
Wong Stephanie / director
05/22/2025
Buy
$1.19
19,111
$23K
19,111
NASDAQ ANTX AN2 Therapeutics
Marks Gilbert Lynn / director
05/22/2025
Buy
$1.19
19,111
$23K
19,111
NASDAQ ANTX AN2 Therapeutics
Aziz Kabeer / director
05/22/2025
Buy
$1.19
19,111
$23K
19,111

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous